Acute pathophysiological processes after ischaemic and traumatic brain injury
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lopez, 2006, Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data, Lancet, 367, 1747, 10.1016/S0140-6736(06)68770-9
Adams, 1993, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke, 24, 35, 10.1161/01.STR.24.1.35
Dutton, 2003, Traumatic brain injury, Current Opinion in Critical Care, 9, 503, 10.1097/00075198-200312000-00007
Cernak, 2010, Traumatic brain injury: an overview of pathobiology with emphasis on military populations, Journal of Cerebral Blood Flow and Metabolism, 30, 255, 10.1038/jcbfm.2009.203
Laurer, 1999, Experimental models of brain trauma, Current Opinion in Neurology, 12, 715, 10.1097/00019052-199912000-00010
Astrup, 1981, Thresholds in cerebral ischemia – the ischemic penumbra, Stroke, 12, 723, 10.1161/01.STR.12.6.723
Heiss, 1983, Functional recovery of cortical neurons as related to degree and duration of ischemia, Annals of Neurology, 14, 294, 10.1002/ana.410140307
Ginsberg, 1999, The acute ischemic penumbra: topography, life span, and therapeutic response, Acta Neurochirurgica. Supplement, 73, 45
Lo, 2005, Exciting, radical, suicidal: how brain cells die after stroke, Stroke, 36, 189, 10.1161/01.STR.0000153069.96296.fd
Dirnagl, 1999, Pathobiology of ischaemic stroke: an integrated view, Trends in Neurosciences, 22, 391, 10.1016/S0166-2236(99)01401-0
Lipton, 1999, Ischemic cell death in brain neurons, Physiological Reviews, 79, 1431, 10.1152/physrev.1999.79.4.1431
Lo, 2003, Mechanisms, challenges and opportunities in stroke, Nature Reviews. Neuroscience, 4, 399, 10.1038/nrn1106
Chen, 1998, Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia, The Journal of Neuroscience, 18, 4914, 10.1523/JNEUROSCI.18-13-04914.1998
Endres, 1999, Neuroprotective effects of gelsolin during murine stroke, The Journal of clinical investigation, 103, 347, 10.1172/JCI4953
Furukawa, 1997, The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons, The Journal of Neuroscience, 17, 8178, 10.1523/JNEUROSCI.17-21-08178.1997
Green, 2004, The pathophysiology of mitochondrial cell death, Science, 305, 626, 10.1126/science.1099320
Frederickson, 1989, Neurobiology of zinc and zinc-containing neurons, International Review of Neurobiology, 31, 145, 10.1016/S0074-7742(08)60279-2
Sorensen, 1998, Rapid disappearance of zinc positive terminals in focal brain ischemia, Brain Research, 812, 265, 10.1016/S0006-8993(98)00943-3
Weiss, 1993, AMPA receptor activation potentiates zinc neurotoxicity, Neuron, 10, 43, 10.1016/0896-6273(93)90240-R
Galluzzi, 2009, Mitochondrial membrane permeabilization in neuronal injury, Nature Reviews. Neuroscience, 10, 481, 10.1038/nrn2665
Fujimura, 1999, Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice, The Journal of Neuroscience, 19, 3414, 10.1523/JNEUROSCI.19-09-03414.1999
Fujimura, 1998, Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats, Journal of Cerebral Blood Flow and Metabolism, 18, 1239, 10.1097/00004647-199811000-00010
Kondo, 1997, Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia, The Journal of Neuroscience, 17, 4180, 10.1523/JNEUROSCI.17-11-04180.1997
Kinouchi, 1991, Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase, Proceedings of the National Academy of Sciences of the United States of America, 88, 11158, 10.1073/pnas.88.24.11158
Sheng, 1999, Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia, Neuroscience, 88, 185, 10.1016/S0306-4522(98)00208-5
Iadecola, 1997, Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene, The Journal of Neuroscience, 17, 9157, 10.1523/JNEUROSCI.17-23-09157.1997
Back, 1996, Induction of spreading depression in the ischemic hemisphere following experimental middle cerebral artery occlusion: effect on infarct morphology, Journal of Cerebral Blood Flow and Metabolism, 16, 202, 10.1097/00004647-199603000-00004
Back, 1994, Cortical negative DC deflections following middle cerebral artery occlusion and KCl-induced spreading depression: effect on blood flow, tissue oxygenation, and electroencephalogram, Journal of Cerebral Blood Flow and Metabolism, 14, 12, 10.1038/jcbfm.1994.3
Nedergaard, 1993, Characterization of cortical depolarizations evoked in focal cerebral ischemia, Journal of Cerebral Blood Flow and Metabolism, 13, 568, 10.1038/jcbfm.1993.74
Busch, 1996, Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging, Journal of Cerebral Blood Flow and Metabolism, 16, 1090, 10.1097/00004647-199611000-00002
Wolf, 1997, Noninvasive near infrared spectroscopy monitoring of regional cerebral blood oxygenation changes during peri-infarct depolarizations in focal cerebral ischemia in the rat, Journal of Cerebral Blood Flow and Metabolism, 17, 950, 10.1097/00004647-199709000-00004
Hoehn-Berlage, 1995, Diffusion-weighted NMR imaging: application to experimental focal cerebral ischemia, NMR in Biomedicine, 8, 345, 10.1002/nbm.1940080708
Mies, 1993, Correlation between peri-infarct DC shifts and ischaemic neuronal damage in rat, Neuroreport, 4, 709, 10.1097/00001756-199306000-00027
Iijima, 1992, Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: effect on volume of ischemic injury, Journal of Cerebral Blood Flow and Metabolism, 12, 727, 10.1038/jcbfm.1992.103
Nakamura, 2010, Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions, Brain, 10.1093/brain/awq117
Colbourne, 1999, Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia, The Journal of Neuroscience, 19, 4200, 10.1523/JNEUROSCI.19-11-04200.1999
van Lookeren Campagne, 1996, Ultrastructural morphological changes are not characteristic of apoptotic cell death following focal cerebral ischaemia in the rat, Neuroscience Letters, 213, 111, 10.1016/0304-3940(96)12839-1
Endres, 2002, Ischemia and stroke, Advances in Experimental Medicine and Biology, 513, 455, 10.1007/978-1-4615-0123-7_17
Ferrer, 2003, Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra, Journal of Neuropathology and Experimental Neurology, 62, 329, 10.1093/jnen/62.4.329
Friedlander, 2003, Apoptosis and caspases in neurodegenerative diseases, The New England Journal of Medicine, 348, 1365, 10.1056/NEJMra022366
Mattson, 2001, Neurodegenerative disorders and ischemic brain diseases, Apoptosis, 6, 69, 10.1023/A:1009676112184
Budd, 2000, Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons, Proceedings of the National Academy of Sciences of the United States of America, 97, 6161, 10.1073/pnas.100121097
Nicotera, 1999, Excitotoxins in neuronal apoptosis and necrosis, Journal of Cerebral Blood Flow and Metabolism, 19, 583, 10.1097/00004647-199906000-00001
Salvesen, 2001, A lysosomal protease enters the death scene, The Journal of clinical investigation, 107, 21, 10.1172/JCI11829
Endres, 1998, Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family, Journal of Cerebral Blood Flow and Metabolism, 18, 238, 10.1097/00004647-199803000-00002
Namura, 1998, Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia, The Journal of Neuroscience, 18, 3659, 10.1523/JNEUROSCI.18-10-03659.1998
Fink, 1998, Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation, Journal of Cerebral Blood Flow and Metabolism, 18, 1071, 10.1097/00004647-199810000-00003
Hara, 1997, Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage, Proceedings of the National Academy of Sciences of the United States of America, 94, 2007, 10.1073/pnas.94.5.2007
Le, 2002, Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation, Proceedings of the National Academy of Sciences of the United States of America, 99, 15188, 10.1073/pnas.232473399
Schielke, 1998, Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice, Journal of Cerebral Blood Flow and Metabolism, 18, 180, 10.1097/00004647-199802000-00009
Danial, 2007, BCL-2 family proteins: critical checkpoints of apoptotic cell death, Clinical Cancer Research, 13, 7254, 10.1158/1078-0432.CCR-07-1598
Lovell, 2008, Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax, Cell, 135, 1074, 10.1016/j.cell.2008.11.010
Billen, 2008, Bcl-XL inhibits membrane permeabilization by competing with Bax, PLoS Biology, 6, e147, 10.1371/journal.pbio.0060147
Galluzzi, 2009, Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes, Cell Death and Differentiation, 16, 1093, 10.1038/cdd.2009.44
Li, 1995, In situ detection of DNA fragmentation after focal cerebral ischemia in mice, Brain Research. Molecular Brain Research, 28, 164, 10.1016/0169-328X(94)00220-9
Li, 1995, Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats, Stroke, 26, 1252, 10.1161/01.STR.26.7.1252
Linnik, 1993, Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats, Stroke, 24, 2002, 10.1161/01.STR.24.12.2002
MacManus, 1993, Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain, Neuroscience Letters, 164, 89, 10.1016/0304-3940(93)90864-H
Tominaga, 1993, Endonuclease activation following focal ischemic injury in the rat brain, Brain Research, 608, 21, 10.1016/0006-8993(93)90768-I
Dirnagl, 2009, Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use, Lancet Neurology, 8, 398, 10.1016/S1474-4422(09)70054-7
Iadecola C, Abe T, Kunz A, et al. Cerebral ischemia and inflammation. In: Mohr JP, editor. Stroke: pathophysiology, diagnosis, and management (5th ed.). Elsevier, in press.
Yi, 2007, Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage, Neurochemistry International, 50, 1014, 10.1016/j.neuint.2007.04.019
Kunz, 2008, Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion, The Journal of Neuroscience, 28, 1649, 10.1523/JNEUROSCI.5205-07.2008
Schwaninger, 2006, NF-kappaB signalling in cerebral ischaemia, Biochemical Society Transactions, 34, 1291, 10.1042/BST0341291
Iadecola, 1999, The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury, The Journal of Experimental Medicine, 189, 719, 10.1084/jem.189.4.719
Kapadia, 2006, Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia, Journal of Neurochemistry, 98, 1718, 10.1111/j.1471-4159.2006.04056.x
Deplanque, 2003, Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment, The Journal of Neuroscience, 23, 6264, 10.1523/JNEUROSCI.23-15-06264.2003
Iwashita, 2007, Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo, The Journal of Pharmacology and Experimental Therapeutics, 320, 1087, 10.1124/jpet.106.115758
Sundararajan, 2005, Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia, Neuroscience, 130, 685, 10.1016/j.neuroscience.2004.10.021
Prass, 2003, Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin, Stroke, 34, 1981, 10.1161/01.STR.0000080381.76409.B2
Wang, 2007, The inflammatory response in stroke, Journal of Neuroimmunology, 184, 53, 10.1016/j.jneuroim.2006.11.014
Liesz, 2009, Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke, Nature Medicine, 15, 192, 10.1038/nm.1927
Yilmaz, 2006, Role of T lymphocytes and interferon-gamma in ischemic stroke, Circulation, 113, 2105, 10.1161/CIRCULATIONAHA.105.593046
Lakhan, 2009, Inflammatory mechanisms in ischemic stroke: therapeutic approaches, Journal of Translational Medicine, 7, 97, 10.1186/1479-5876-7-97
Campanella, 2002, Flow cytometric analysis of inflammatory cells in ischemic rat brain, Stroke, 33, 586, 10.1161/hs0202.103399
Hurn, 2007, T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation, Journal of Cerebral Blood Flow and Metabolism, 27, 1798, 10.1038/sj.jcbfm.9600482
Shichita, 2009, Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury, Nature Medicine, 15, 946, 10.1038/nm.1999
Planas, 2009, Regulatory T cells protect the brain after stroke, Nature Medicine, 15, 138, 10.1038/nm0209-138
del Zoppo, 1991, Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons, Stroke, 22, 1276, 10.1161/01.STR.22.10.1276
Ritter, 2000, Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke, Stroke, 31, 1153, 10.1161/01.STR.31.5.1153
Barone, 1999, Inflammatory mediators and stroke: new opportunities for novel therapeutics, Journal of Cerebral Blood Flow and Metabolism, 19, 819, 10.1097/00004647-199908000-00001
Frijns, 2002, Inflammatory cell adhesion molecules in ischemic cerebrovascular disease, Stroke, 33, 2115, 10.1161/01.STR.0000021902.33129.69
Ogata, 2008, Chapter 5 Neuropathology of ischemic brain injury, Handbook of Clinical Neurology, 92, 93, 10.1016/S0072-9752(08)01905-2
Wunder, 2009, Non-invasive visualization of CNS inflammation with nuclear and optical imaging, Neuroscience, 158, 1161, 10.1016/j.neuroscience.2008.10.005
Tarozzo, 2002, Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat, The European Journal of Neuroscience, 15, 1663, 10.1046/j.1460-9568.2002.02007.x
Yrjanheikki, 1999, A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window, Proceedings of the National Academy of Sciences of the United States of America, 96, 13496, 10.1073/pnas.96.23.13496
Priller, 2001, Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment, Nature Medicine, 7, 1356, 10.1038/nm1201-1356
Letterio, 2000, Murine models define the role of TGF-beta as a master regulator of immune cell function, Cytokine & Growth Factor Reviews, 11, 81, 10.1016/S1359-6101(99)00031-3
Ruscher, 2002, Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model, The Journal of Neuroscience, 22, 10291, 10.1523/JNEUROSCI.22-23-10291.2002
Trendelenburg, 2002, Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia, The Journal of Neuroscience, 22, 5879, 10.1523/JNEUROSCI.22-14-05879.2002
Murphy, 2007, Nitric oxide, ischaemia and brain inflammation, Biochemical Society Transactions, 35, 1133, 10.1042/BST0351133
Garthwaite, 2008, Concepts of neural nitric oxide-mediated transmission, The European Journal of Neuroscience, 27, 2783, 10.1111/j.1460-9568.2008.06285.x
Grandati, 1997, Calcium-independent NO-synthase activity and nitrites/nitrates production in transient focal cerebral ischaemia in mice, British Journal of Pharmacology, 122, 625, 10.1038/sj.bjp.0701427
Hirabayashi, 2000, Nitrotyrosine generation via inducible nitric oxide synthase in vascular wall in focal ischemia-reperfusion, Brain Research, 852, 319, 10.1016/S0006-8993(99)02117-4
Iadecola, 1996, Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia, Stroke, 27, 1373, 10.1161/01.STR.27.8.1373
Iadecola, 1995, Inducible nitric oxide synthase gene expression in brain following cerebral ischemia, Journal of Cerebral Blood Flow and Metabolism, 15, 378, 10.1038/jcbfm.1995.47
Iadecola, 1995, Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage, The American Journal of Physiology, 268, R286
Nagayama, 1998, Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats, Journal of Cerebral Blood Flow and Metabolism, 18, 1107, 10.1097/00004647-199810000-00007
Zhao, 2000, Gene-dosing effect and persistence of reduction in ischemic brain injury in mice lacking inducible nitric oxide synthase, Brain Research, 872, 215, 10.1016/S0006-8993(00)02459-8
Pruss, 2008, Inducible nitric oxide synthase does not mediate brain damage after transient focal cerebral ischemia in mice, Journal of Cerebral Blood Flow and Metabolism, 28, 526, 10.1038/sj.jcbfm.9600550
Beckman, 1990, Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide, Proceedings of the National Academy of Sciences of the United States of America, 87, 1620, 10.1073/pnas.87.4.1620
Pacher, 2007, Nitric oxide and peroxynitrite in health and disease, Physiological Reviews, 87, 315, 10.1152/physrev.00029.2006
Phillis, 2006, Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders, Brain Research Reviews, 52, 201, 10.1016/j.brainresrev.2006.02.002
Minghetti, 2007, Role of COX-2 in inflammatory and degenerative brain diseases, Sub-cellular Biochemistry, 42, 127, 10.1007/1-4020-5688-5_5
Miettinen, 1997, Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-d-aspartic acid-receptors and phospholipase A2, Proceedings of the National Academy of Sciences of the United States of America, 94, 6500, 10.1073/pnas.94.12.6500
Nogawa, 1997, Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage, The Journal of Neuroscience, 17, 2746, 10.1523/JNEUROSCI.17-08-02746.1997
Nogawa, 1998, Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia, Proceedings of the National Academy of Sciences of the United States of America, 95, 10966, 10.1073/pnas.95.18.10966
Nagayama, 1999, The cyclooxygenase-2 inhibitor NS-398 ameliorates ischemic brain injury in wild-type mice but not in mice with deletion of the inducible nitric oxide synthase gene, Journal of Cerebral Blood Flow and Metabolism, 19, 1213, 10.1097/00004647-199911000-00005
Iadecola, 2001, Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice, Proceedings of the National Academy of Sciences of the United States of America, 98, 1294, 10.1073/pnas.98.3.1294
Dore, 2003, Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction, Annals of Neurology, 54, 155, 10.1002/ana.10612
Candelario-Jalil, 2008, Cyclooxygenase inhibition in ischemic brain injury, Current Pharmaceutical Design, 14, 1401, 10.2174/138161208784480216
Kunz, 2007, Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species, Journal of Cerebral Blood Flow and Metabolism, 27, 545, 10.1038/sj.jcbfm.9600369
Manabe, 2004, Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity, Annals of Neurology, 55, 668, 10.1002/ana.20078
Ahmad, 2006, Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage, Toxicological Sciences, 89, 265, 10.1093/toxsci/kfj022
Kawano, 2006, Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity, Nature Medicine, 12, 225, 10.1038/nm1362
Zhou, 2008, Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway, Neurobiology of Disease, 29, 543, 10.1016/j.nbd.2007.11.010
Marsh, 2009, Toll-like receptor signaling in endogenous neuroprotection and stroke, Neuroscience, 158, 1007, 10.1016/j.neuroscience.2008.07.067
Tang, 2007, Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits, Proceedings of the National Academy of Sciences of the United States of America, 104, 13798, 10.1073/pnas.0702553104
Caso, 2007, Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke, Circulation, 115, 1599, 10.1161/CIRCULATIONAHA.106.603431
Lehnardt, 2007, Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia, Journal of Neuroimmunology, 190, 28, 10.1016/j.jneuroim.2007.07.023
Meisel, 2005, Central nervous system injury-induced immune deficiency syndrome, Nature Reviews. Neuroscience, 6, 775, 10.1038/nrn1765
Prass, 2003, Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation, The Journal of Experimental Medicine, 198, 725, 10.1084/jem.20021098
Iadecola, 2004, Neurovascular regulation in the normal brain and in Alzheimer’s disease, Nature Reviews. Neuroscience, 5, 347, 10.1038/nrn1387
Gasche, 1999, Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction, Journal of Cerebral Blood Flow and Metabolism, 19, 1020, 10.1097/00004647-199909000-00010
Heo, 1999, Matrix metalloproteinases increase very early during experimental focal cerebral ischemia, Journal of Cerebral Blood Flow and Metabolism, 19, 624, 10.1097/00004647-199906000-00005
Lapchak, 2000, Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke, Stroke, 31, 3034, 10.1161/01.STR.31.12.3034
Clark, 1997, Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia, Neuroscience Letters, 238, 53, 10.1016/S0304-3940(97)00859-8
Montaner, 2001, Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment, Stroke, 32, 1759, 10.1161/01.STR.32.8.1759
Rosenberg, 1997, Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat, Neurology, 48, 921, 10.1212/WNL.48.4.921
Asahi, 2001, Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia, The Journal of Neuroscience, 21, 7724, 10.1523/JNEUROSCI.21-19-07724.2001
Morales, 2005, Experimental models of traumatic brain injury: do we really need to build a better mousetrap?, Neuroscience, 136, 971, 10.1016/j.neuroscience.2005.08.030
Faden, 1989, The role of excitatory amino acids and NMDA receptors in traumatic brain injury, Science, 244, 798, 10.1126/science.2567056
Coles, 2004, Defining ischemic burden after traumatic brain injury using 15O PET imaging of cerebral physiology, Journal of Cerebral Blood Flow and Metabolism, 24, 191, 10.1097/01.WCB.0000100045.07481.DE
Ginsberg, 1997, Uncoupling of local cerebral glucose metabolism and blood flow after acute fluid-percussion injury in rats, The American Journal of Physiology, 272, H2859
Donkin, 2010, Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments, Current Opinion in Neurology, 23, 293, 10.1097/WCO.0b013e328337f451
Marmarou, 2006, Predominance of cellular edema in traumatic brain swelling in patients with severe head injuries, Journal of Neurosurgery, 104, 720, 10.3171/jns.2006.104.5.720
Unterberg, 2004, Edema and brain trauma, Neuroscience, 129, 1021, 10.1016/j.neuroscience.2004.06.046
Del Zoppo, 1995, Why do all drugs work in animals but none in stroke patients? 1. Drugs promoting cerebral blood flow, Journal of Internal Medicine, 237, 79, 10.1111/j.1365-2796.1995.tb01144.x
del Zoppo, 1998, Clinical trials in acute stroke: why have they not been successful?, Neurology, 51, S59, 10.1212/WNL.51.3_Suppl_3.S59
Dirnagl, 2009, Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice, British Journal of Pharmacology, 157, 1154, 10.1111/j.1476-5381.2009.00211.x
Gladstone, 2002, Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions, Stroke, 33, 2123, 10.1161/01.STR.0000025518.34157.51